SYNH News and Press, Syneos Health Inc.

Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...

Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...

Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...

Syneos Health Inc. (SYNH) is expected to report $0.68 for Q3 2023

MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of private investment fi...

2023-09-26 17:51:49 ET More on Civitas Resources, Hayward Holdings, etc. Compare metrics for CIVI to HAYW, SYNH Civitas Resources: Essential Basin Diversification Syneos Health: Pre-Vote Checks, Trading At 1.7% Discount To PE Offer Hayward Holdings upgraded t...

Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600 Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600 PR Newswire NEW YORK , Sept. 26, 2023 /PRNewswire/ -- S&P Small...

MORRISVILLE, N.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, has announced the appointment of Terttu Haring, MD, as President, Clinical Sites & Patients. With nearly 30 years of experience, ...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - September 24, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - September 22, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm,...